Rivaroxaban News and Research

RSS
Mortality, morbidity rates linked with AF remain 'unacceptably high' despite new treatments

Mortality, morbidity rates linked with AF remain 'unacceptably high' despite new treatments

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

J&JPRD announces rivaroxaban Phase 3 trial results against venous thromboembolism

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Apixaban drug raises hope for DVT prevention in patients undergoing hip replacement surgery

Apixaban drug raises hope for DVT prevention in patients undergoing hip replacement surgery

J&JPRD submits New Drug Application to FDA for rivaroxaban

J&JPRD submits New Drug Application to FDA for rivaroxaban

New era for anticoagulant therapy

New era for anticoagulant therapy

New research focusing on VTE presented at ASH Annual Meeting

New research focusing on VTE presented at ASH Annual Meeting

Sermo releases report on potential replacements for warfarin

Sermo releases report on potential replacements for warfarin

Anti-stroke blood thinner shows promise in large clinical trials

Anti-stroke blood thinner shows promise in large clinical trials

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association

Emerging blood thinners to prevent stroke

Emerging blood thinners to prevent stroke

XARELTO achieves net clinical benefit in treatment of patients with DVT

XARELTO achieves net clinical benefit in treatment of patients with DVT

Phase 3 EINSTEIN-DVT clinical trial data can transform deep vein thrombosis treatment

Phase 3 EINSTEIN-DVT clinical trial data can transform deep vein thrombosis treatment

New oral blood-thinning drugs may have dangerous interactions when taken with prescription drugs : Study

New oral blood-thinning drugs may have dangerous interactions when taken with prescription drugs : Study

J&JPRD announces clinical results of new oral anticoagulant therapy for venous thromboembolism

J&JPRD announces clinical results of new oral anticoagulant therapy for venous thromboembolism

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

New approaches to prevent blood clots

New approaches to prevent blood clots

Rivaroxaban shows promise in patients with acute coronary syndrome

Rivaroxaban shows promise in patients with acute coronary syndrome

Bayer's new oral anticoagulant Xarelto (Rivaroxaban) gets European licence

Bayer's new oral anticoagulant Xarelto (Rivaroxaban) gets European licence